Filing Flows › Baldwin Insurance Group (BWIN) › Stock forecast & fair value
Baldwin Insurance Group (BWIN) stock forecast and fair value
Baldwin Insurance Group (BWIN) trades at $31.98. 6 analysts' median price target is $32.50 (+2%), from $32.00 to $32.50. Across 5 valuation methods the middle fair value is $4.43 (-86%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| Residual income | $2.65 | $2.77 | $2.89 | -91% |
| P/B vs ROE (insurer peers) | $0.00 | $4.43 | $18.16 | -86% |
| Analysts' price targets | $32.00 | $32.42 | $32.50 | +1% |
| Stage-weighted value (financial (bank / insurer)) | $1.33 | $3.60 | $10.52 | -89% |
| Combined forecast (3 months) | $26.19 | $33.25 | $41.20 | +4% |
Baldwin Insurance Group's latest quarter
Baldwin Insurance Group, Q2 2026: revenue $493M (+30% year over year), operating margin -1.7%, net loss $56.0M, operating cash flow $45.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for BWIN stock?
The median of 6 analysts' 12-month targets is $32.50, +2% from $31.98; the range is $32.00 to $32.50. The average rating is hold.
What is Baldwin Insurance Group's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $2.77 and $33.25, with a middle value of $4.43 against a price of $31.98. Each method's assumptions are on the page.
Does Baldwin Insurance Group usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is BWIN stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.